| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6193018 | Journal of Thoracic Oncology | 2015 | 7 Pages |
Abstract
Our data suggest that mucinous adenocarcinoma is typified by (1) frequent KRAS mutations and a growing list of gene fusions, but rare TP53 mutations, (2) a low mutation burden overall, and (3) a recurrence-free survival similar to stage-matched nonmucinous tumors, with recurrences limited to the lungs.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hyo Sup MD, PhD, Mari- MD, Zongli PhD, Matthew BSc, Yoon Jin MD, Quan BSc, Maristela MD, PhD, Long MD, PhD, Rebecca S. MD, MPH, A. John PhD,